Immunocore presents new data on tebentafusp in metastatic cutaneous melanoma (mCM) and uveal melanoma (mUM) at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access